The hormone leptin has been shown to be an afferent signal in a negative-feedback loop regulating body weight, and consequently, the administration of the gene product for the treatment of obesity ...

Meanwhile, hundreds of trials for general obesity are currently recruiting despite the uncertainties in U.S. medical research funding. 2025 KFF Health News. Distributed by Tribune Content Agency, LLC.

Background/aims Obesity and sleep deprivation are two epidemics that pervade developed nations. Their rates have been steadily rising worldwide, especially in the USA. This short communication will ...

TOPLINE: In individuals with obesity, 90 minutes of cold exposure increases energy expenditure by 18% but also raises energy intake and causes significant discomfort. METHODOLOGY: There is a ...

Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies targeting metabolic diseases.

Today, a brief rundown of news involving Regeneron and Bluebird bio, as well as updates from Atai Life Sciences, Alto Neuroscience and UniQure that you may have missed. Regeneron Pharmaceuticals on ...

Metformin has a moderate although statistically significant effect on reducing knee pain among patients with knee osteoarthritis and overweight or obesity, according to study findings published in the ...